Add Company
Join Now

Sunflower Therapeutics Revenue and Competitors

License our Company Data API

Hingham, MA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Sunflower Therapeutics's estimated annual revenue is currently $3.6M per year.(i)
  • Sunflower Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Sunflower Therapeutics has 23 Employees.(i)
  • Sunflower Therapeutics grew their employee count by 5% last year.

Sunflower Therapeutics's People

NameTitleEmail/Phone
1
Founder, CEO/PresidentReveal Email/Phone
2
Director Engineering OperationsReveal Email/Phone
3
Director R&DReveal Email/Phone
4
Software Product ManagerReveal Email/Phone
5
Lead Software EngineerReveal Email/Phone
6
Scientist - Strain Engineering & FermentationReveal Email/Phone
7
BioengineerReveal Email/Phone
8
Senior Research Associate, Protein Expression and CharacterizationReveal Email/Phone
9
Bioprocess EngineerReveal Email/Phone
10
Research Associate, Strain Creation and FermentationReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Sunflower Therapeutics?

Sunflower Therapeutics is a unique biotechnology start-up focused on dramatically reducing the time and cost to develop and manufacture biologics for patients around the world. With a genetically-optimized host, data-driven process development, and a novel, ‘right-sized’ manufacturing unit, the experienced Sunflower team is creating an efficient, patient-centered, end-to-end drug production platform that we plan to deploy worldwide.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$3.6M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4M250%N/A
#2
$5.3M26-73%N/A
#3
$5.7M280%N/A
#4
$5.2M317%N/A
#5
N/A3260%N/A